WAYSTAR HOLDING CORP (WAY)
Health Care · healthcare software · NASDAQ
Waystar provides a cloud-based software platform that automates and optimizes revenue cycle management for healthcare providers.
What WAYSTAR HOLDING CORP does
Waystar Holding Corp. provides a cloud-based healthcare software platform that simplifies healthcare payments and revenue cycle management. Its solutions automate workflows, improve financial performance, and enhance the experience for healthcare providers and patients.
Themes: revenue cycle management, healthcare automation, health tech, healthcare payments
Fundamentals
- Price$25.01 as of 2026-08-21 close
- Market cap$4.8B as of 2026-08-21
- 1-year return-30.0% 2025-08-21 close $35.75 → 2026-08-21 close $25.01
- P/E34.91 as of 2026-08-24
- Net margin+11.2% as of 2026-08-24
- Gross margin+69.1% as of 2026-08-24
- ROE+3.6% as of 2026-08-24
- Debt / equity0.37 as of 2026-08-24
- Revenue growth (YoY)+19.2% as of 2026-08-24
- Revenue CAGR (3y)+16.0% SEC XBRL
- Beta1.20 as of 2026-08-24
- Last reported earnings2026-07-29 SEC EDGAR Form 8-K (Item 2.02)
How WAY compares in its sector
- price-to-earnings ratiomiddle range 203 covered Health Care peers, as of 2026-08-24
- net profit margintop 25% 504 covered Health Care peers, as of 2026-08-24
- operating margintop 25% 504 covered Health Care peers, as of 2026-08-24
- gross marginmiddle range 384 covered Health Care peers, as of 2026-08-24
- return on equitymiddle range 576 covered Health Care peers, as of 2026-08-24
- 3-year revenue CAGRmiddle range 402 covered Health Care peers
- free cash flow (absolute dollars, latest fiscal year)top 25% 493 covered Health Care peers, as of FY2025
Position among covered Health Care companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Top 10 scores & list membership
WAY is not currently in any published Top 10 list. Its scores are below.
Long-term score
Not scored for the long-term list: no shareholder return data.
Short-term score
62.6 #108 of 1,704 scored · #29 of 240 in Health Care
Volume and participation 70th: it gapped 3.8% above the previous close and has not traded back through the level it left behind — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed; momentum 69th: over the past 3 months this stock beat the market by 29.7 percentage points; weakest is catalysts 45th: analysts have cut their average price target by 0.4% since the prior reading.
Scores as of 21 Aug 2026. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100. A list is a published formula and its output, not a recommendation. Method version 2.
How WAYSTAR HOLDING CORP looks technically
WAYSTAR HOLDING CORP (WAY) is trading 4.0% below its 200-day average, the long-term trend line — a long-term downtrend. Its 50-day average crossed below its 200-day average about 249 trading days ago — a "death cross", a bearish long-term signal. There is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 16, below the 25 that marks a real trend). Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 60, neither overbought (above 70) nor oversold (below 30). It made a new 20-day high about 7 trading days ago. It is 39.7% below its highest point of the past year.
Trend
7
| Distance from the 200-day | it is trading 4.0% below its 200-day average, the long-term trend line — a long-term downtrend | -4.0% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $22.11 | $22.11 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $26.04 | $26.04 |
| Swing structure | its recent peaks and dips disagree — one of them is rising while the other is not, so there is no clean up or down pattern in the swings | mixed — one of the two is not confirming |
| Last swing turn | its last significant turn was a swing high 7 calendar days ago — the swings before that are what the structure reading is measured on | 7 sessions |
| Since the 50/200 cross | its 50-day average crossed below its 200-day average about 249 trading days ago — a "death cross", a bearish long-term signal | 249 sessions |
| Trend strength (14-day ADX) | there is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 16, below the 25 that marks a real trend) | 15.9 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 60, neither overbought (above 70) nor oversold (below 30) | 60.1 |
|---|---|---|
| Position in its 14-day range | it is trading in the upper half of its 14-day range ($22.65 to $25.87) — its "stochastic" reading is 73 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been slipping within that range over the last few sessions. | 73.3 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, is in positive territory (momentum leaning bullish) | 13 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $41.47 | $41.47 |
|---|---|---|
| From the 52-week high | it is 39.7% below its 52-week high (its highest price of the past year) | -39.7% |
| Above the 52-week low | it is 44.9% above its 52-week low (its lowest price of the past year) | +44.9% |
| Below the 52-week high | it is 39.7% below its highest point of the past year | 39.7% |
| Since a 20-day breakout | it made a new 20-day high about 7 trading days ago | 7 sessions |
| Since a 55-day breakout | it made a new 55-day high about 7 trading days ago | 7 sessions |
| All-time high | its highest closing price on record is $48.11 (set on 2025-02-18) | $48.11 |
| Given back of the 52-week move | over the past year its closes ranged ($17.31 to $40.89), and it has recovered roughly a third of its fall from last year’s high — 33% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $31.88 to $32.64. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 32.6% |
| From the all-time high | it is 48.0% below its all-time high | -48.0% |
| Nearest price level | it is trading 1.4% above a support level at $24.66 — a price it turned at twice since 2026-07-07, most recently on 2026-07-29. Since 2024-08-21 it has 3 such levels below the current price and 15 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | -1.4% |
| All-time low | its lowest closing price on record is $17.26 (set on 2026-06-22) | $17.26 |
| Above the all-time low | it is 44.9% above its all-time low | +44.9% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are about average versus its own recent 6-month history | 34th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $1.08 between its high and its low — about 4.3% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $1.08 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $21.57 and $26.22 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $21.57 – $23.89 – $26.22 |
| Typical daily range (% of price) | its price moves about 4.3% in a typical session — about typical for the companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 4.3% |
| Stretch from the 200-day average | it is trading 1.0 daily range below its 200-day average price (4.0% below it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 1.0 daily range below its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.97× |
|---|
Analyst
2
| Change in the average price target | analysts have cut their average price target by 0.4% since the prior reading | -0.4% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
2
| Since a doji | 1 session ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 1 session ago |
|---|---|---|
| Since a bullish engulfing | 7 sessions ago it opened below the previous session's close and finished above that session's open — a "bullish engulfing" pair, where one up day more than undid the down day before it | 7 sessions ago |
Price gaps
3
| Gap at the open | it opened on 2026-08-21 0.6% below the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | -0.6% |
|---|---|---|
| Open gap | it gapped 3.8% above the previous close 10 sessions ago and has not traded back through the level it left behind at 23.37 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | +3.8% |
| Gap filled | a 2.2% gap up opened on 2026-08-18 has been "filled" 3 sessions ago — price traded back through the level the gap left behind, and it closed again during the very session that opened it | 3 sessions ago |
Price streaks
1
| Closing streak | it closed higher in its latest session, after a session that did not close higher — a single up day rather than a run | 1 session up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock beat the market by 13.9 percentage points (the stock gained 16.3% while the market gained 2.3%) | +13.9% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock beat the market by 29.7 percentage points (the stock gained 32.8% while the market gained 3.1%) | +29.7% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 11.3 percentage points (the stock lost 0.2% while the market gained 11.1%) | -11.3% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 50.5 percentage points (the stock lost 30.0% while the market gained 20.5%) | -50.5% |
Signal agreement
2
| Bullish technical signals | 2 of the 9 technical signals we can compute for it are currently in a bullish state: MACD momentum is positive, trading above the Ichimoku cloud — these describe past price behaviour, not a forecast | 2 of 9 |
|---|---|---|
| Bearish technical signals | 3 of the 9 technical signals we can compute for it are currently in a bearish state: a "death cross" — its 50-day average is below its 200-day, trading below its 200-day average, lagging the market over 6 months — these describe past price behaviour, not a forecast | 3 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 13% above the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-07-16 and projected forward over today's price, the side traders read as an established uptrend, with the band below acting as the level that would have to give way. The band itself is moderate, spanning 3.6% of the share price. | +12.7% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 7% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $23.44 — a volume-weighted average of daily closes over 157 sessions, not a true tick-by-tick VWAP. | +6.7% |
|---|---|---|
| Vs the average paid since it last reported | the price is 6% above the average price paid since it last reported on 2026-07-29 (its 10-Q), so the typical buyer over that stretch is showing a gain. That average is $23.55 — a volume-weighted average of daily closes over 18 sessions, not a true tick-by-tick VWAP. | +6.2% |
Price levels it has turned at before
WAY last closed at $25.01 on 2026-08-21. Since 2024-08-21 it has turned at 3 prices below its last close and 15 above; the 3 nearest below and the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $24.66 | Support | 1.4% below the last close | turned there twice · 2026-07-07 to 2026-07-29 |
| $25.82 | Resistance | 3.2% above the last close | turned there twice · 2024-09-11 to 2026-08-14 |
| $26.37 | Resistance | 5.4% above the last close | turned there three times · 2024-09-20 to 2026-02-19 |
| $27.06 | Resistance | 8.2% above the last close | turned there twice · 2024-10-22 to 2026-04-21 |
| $21.03 | Support | 15.9% below the last close | turned there twice · 2026-02-17 to 2026-04-10 |
| $20.27 | Support | 19.0% below the last close | turned there twice · 2026-05-19 to 2026-07-30 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
No Elliott-wave labelling currently fits its swings: the recent highs and lows do not satisfy the three rules a five-wave count has to obey, so there is no count to show rather than a count we are unsure about.
Read from daily closes as of 2026-08-21.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading below the 200-day moving average · Pulled back from the 12-month high · trendless / choppy (low ADX) · lagging the market · Trading above the Ichimoku cloud · Near a support level (sitting on a price it has bounced off before) | Learn: moving average · golden cross · adx · rsi · breakout · fifty two week high low
Based on daily closing prices as of 2026-08-21. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingStrong Buy (1.29 mean, 1=Strong Buy…5=Strong Sell) — 23 analysts
- Mean price target$33.17 range $27.00 – $44.00; median $32.00
Analyst estimates, as of 2026-08-18. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for WAY
- Consensus EPS estimate$0.4081 next reporting period, as of 2026-08-18
Change over time is not available yet: it needs two readings of the same reporting period at least 30 days apart, and we have been recording these estimates since 2026-08-04. An estimate for a DIFFERENT quarter is not a revision, so a reading from before the last report is never compared with one after it.
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["significant intangible assets and goodwill which may be subject to impairment charges","dependence on complex regulatory and healthcare reimbursement environments","substantial long-term debt levels"]
What changed in the latest 10-Q
AI-assisted comparison of WAY's 10-Q filed 2026-04-29 against the prior one filed 2025-10-29.
Management's Discussion & Analysis (MD&A)
- Added:
- Newer filing mentions Waystar AltitudeAI as proprietary AI engine utilizing multi-model approach with machine learning, large language models, and generative and agentic AI
- Newer filing states Q1 2026 revenue was $313.9 million (22.4% increase YoY) with net income of $43.3 million and Adjusted EBITDA of $135.4 million (25.7% increase YoY)
- Newer filing reports 1,433 clients generating over $100,000 for 12 months ended March 31, 2026, with Net Revenue Retention Rate of 110.5%
- Newer filing states 2025 facilitated over 7.5 billion healthcare payment transactions including over $2.4 trillion in gross claims volume spanning approximately 60% of patients and one-in-three hospital discharges
- Newer filing references 2025 Form 10-K instead of 2024 Form 10-K
- Removed:
- Older filing contained Initial Public Offering section describing June 2024 IPO details, which is absent from newer filing
- Older filing stated company serves 17 of top 20 U.S. News Best Hospitals; newer filing states 16 of top 20
- Older filing described platform as driven by 'sophisticated, automated, and curated rules engine'; newer filing describes it as 'sophisticated, automated, and AI-powered engine'
- Older filing stated 2024 facilitated over six billion healthcare payment transactions with over $1.8 trillion in gross claims volume spanning approximately 50% of patients
- Older filing referenced 'embedded machine learning, advanced algorithms, and other in-house AI technologies'; newer filing references Waystar AltitudeAI specifically
- Older filing reported nine months ended September 30, 2025 metrics; newer filing reports three months ended March 31, 2026 metrics
- Older filing reported 1,306 clients as of September 30, 2025 with Net Revenue Retention Rate of 113.1%
- Older filing stated Iodine acquisition total purchase price of $1.25 billion with $458.6 million in cash consideration
- Older filing stated company paid $1.4 million and $4.6 million in certain expenses for three and nine months ended September 30, 2025 related to secondary offerings
- Reworded:
- Overview opening: older filing says 'should be read in conjunction with' while newer says 'should be read in conjunction with' - substantively same but reference documents changed from 2024 to 2025 Form 10-K
- Older filing: 'outside the Company's control' changed to 'outside our control' in newer filing
- Description of simplifying healthcare payments: older says 'simplifies healthcare payments' while newer adds specificity 'simplifies healthcare payments for providers across the continuum of care'
- Older filing: 'be reimbursed correctly' changed to 'ensure accurate reimbursement' in newer filing
- Older filing: 'enriches data integrity' changed to 'strengthens data integrity' in newer filing
- Older filing: 'Our business model is designed such that' changed to 'Our business model aligns with' in newer filing
- Secondary Offerings section: older referred to 'Secondary Offerings' subsection; newer refers to 'Secondary Offering' (singular) as separate section header
- Notes:
- The two filings cover different reporting periods (Q1 2026 for newer vs. nine-month period ending September 30, 2025 for older), making some metric comparisons reflect different time periods rather than operational changes
- The Iodine Acquisition section in the older filing was truncated mid-sentence in the source provided, limiting ability to assess complete removal or wording changes in that section
Risk Factors
The two filings could not be meaningfully compared for this section.
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
0 open-market purchases and 4 open-market sales by insiders in the last 90 days.
- Last 30 days0 buys · 2 sells ($2M) — 1 selling insider
- Last 90 days0 buys · 4 sells ($4M) — 1 selling insider
- Last 180 days0 buys · 4 sells ($4M) — 1 selling insider
Activity heuristic: net selling (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-08-13. As of 2026-08-24.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about WAY's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
6 institutional 13F filers reported holding WAY as of 2026-03-31 (quarter-end position, filed within 45 days).
- Distinct 13F filers 6
- Reported shares held 36,623,385
- Reported value $882,989,813
reported quarterly holdings change (2025-12-31 → 2026-03-31): 0 new, 4 increased, 2 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Short interest (FINRA)
WAY had 14,585,787 shares of reported short interest as of the 2026-07-31 FINRA settlement date (delayed, bi-monthly; not real-time).
WAY had 7.61% of its shares outstanding sold short as of the 2026-07-31 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 4.97 days to cover at the same settlement.
- Reported short interest (shares) 14,585,787
- Short interest (% of shares outstanding) 7.61%
- Prior settlement (shares) 13,593,276
- Reported change 7.3%
- Days to cover (reported) 4.97
Reported to FINRA as of the 2026-07-31 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Change Healthcare (UHG)
- Veradigm (MDRX)
- R1 RCM (RCM)
- Epic Systems
- Cerner (Oracle)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Frequently asked questions
What does WAYSTAR HOLDING CORP (WAY) do?
Waystar Holding Corp. provides a cloud-based healthcare software platform that simplifies healthcare payments and revenue cycle management. Its solutions automate workflows, improve financial performance, and enhance the experience for healthcare providers and patients.
What sector is WAYSTAR HOLDING CORP (WAY) in?
WAYSTAR HOLDING CORP (WAY) is classified in the Health Care sector. Its industry is healthcare software. It trades on NASDAQ.
Who are WAYSTAR HOLDING CORP's (WAY) competitors?
Notable peers of WAYSTAR HOLDING CORP (WAY) include Change Healthcare, Veradigm, R1 RCM, Epic Systems and Cerner (Oracle). This peer set is informational only — not financial advice.
Is WAYSTAR HOLDING CORP (WAY) overbought or oversold right now?
WAYSTAR HOLDING CORP (WAY) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 60, in the neutral middle (as of 2026-08-21). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on WAY come from?
Fundamentals and prices come from market data, as of 2026-08-24; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.